Original Research
Published on 15 May 2025
Bispecific antibody targeting shared indel-derived neoantigen of APC
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1574958
- 4,073 views
- 1 citation
164 articles related to "Antibody Targeting"
Articles
Original Research
Published on 21 Jun 2019
Therapeutic Bispecific T-Cell Engager Antibody Targeting the Transferrin Receptor
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2019.01396
- 17,892 views
- 18 citations
Original Research
Published on 11 Jun 2019
A Human-Derived Monoclonal Antibody Targeting Extracellular Connexin Domain Selectively Modulates Hemichannel Function
in Membrane Physiology and Membrane Biophysics
Frontiers in Physiology
doi 10.3389/fphys.2019.00392
- 5,941 views
- 24 citations
Original Research
Published on 22 Mar 2021
A Predictive Model of Antibody Binding in the Presence of IgG-Interacting Bacterial Surface Proteins
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.629103
- 8,338 views
- 11 citations
Original Research
Published on 16 Feb 2022
Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2022.835690
- 10,695 views
- 27 citations
Original Research
Published on 03 Dec 2021
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2021.775151
- 8,348 views
- 6 citations
Original Research
Published on 26 Nov 2019
A Novel Single Domain Antibody Targeting FliC Flagellin of Salmonella enterica for Effective Inhibition of Host Cell Invasion
in Food Microbiology
Frontiers in Microbiology
doi 10.3389/fmicb.2019.02665
- 7,949 views
- 20 citations
Original Research
Published on 28 Jun 2022
Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.885424
- 19,916 views
- 25 citations
Original Research
Published on 11 Aug 2022
A Novel Tolerogenic Antibody Targeting Disulfide-Modified Autoantigen Effectively Prevents Type 1 Diabetes in NOD Mice
in Autoimmune and Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2022.877022
- 4,199 views
- 4 citations
Original Research
Published on 24 Sep 2019
Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2019.00945
- 7,194 views
- 20 citations
Original Research
Published on 10 Feb 2023
A novel shark single-domain antibody targeting OGT as a tool for detection and intracellular localization
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1062656
- 6,884 views
- 12 citations
Original Research
Published on 01 Nov 2024
Characterization of a plant-derived monoclonal antibody targeting extracellular enveloped virions of Monkeypox virus
in Plant Biotechnology
Frontiers in Plant Science
doi 10.3389/fpls.2024.1481452
- 3,230 views
- 4 citations
Original Research
Published on 02 Dec 2021
A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.778978
- 39,071 views
- 48 citations
Original Research
Published on 10 Feb 2022
Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis
in Antigen Presenting Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2022.784528
- 6,535 views
- 3 citations
Original Research
Published on 07 Nov 2023
Humanized single-domain antibody targeting HER2 enhances function of chimeric antigen receptor T cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1258156
- 4,634 views
- 6 citations
Case Report
Published on 10 Feb 2026
A rare case report of relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type, treated with Epcoritamab: results obtained and lesson learned
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1710502
- 607 views